Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
Date:2/1/2011

n patent litigation and other legal matters, including the receipt of a legal settlement following the favorable closure to a matter with Medinol, Ltd. in the fourth quarter of 2010, the reduction of previously recorded reserves associated with certain litigation matters in the fourth quarter of 2009, and charges related to losses associated with other matters during 2009, none of which reflect expected on-going operating expenses. Accordingly, management excluded these (credits) charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance and for comparison to the Company's past operating performance.
  • Discrete tax items - These items represent adjustments of certain tax positions, which were initially established in prior periods as a result of acquisition-, divestiture-, restructuring- or litigation-related charges (credits). These adjustments do not reflect expected on-going operating results. Accordingly, management excluded these amounts for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance and for comparison to the Company's past operating performance.

  • Amortization expense - Amortization expense is a non-cash charge and does not impact the Company's liquidity or compliance with the covenants included in its debt agreements. Management removes the impact of amortization from the Company's operating performance to assist in assessing the Company's cash generated from operations. Management believes this is a critical metric for the Company in measuring the Company's ability to generate cash and pay down debt. Therefore, amortization expense is excluded from management's assessment of operating performance and is also excluded from the measures management uses to set employee compensation. Accordingly, management believes this may be useful information to users of its financial statements and
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

    Related medicine technology :

    1. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
    2. Boston Scientific Responds to DOJ Civil Lawsuit
    3. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
    4. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
    5. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
    6. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
    7. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
    8. Boston Scientific to Acquire Atritech
    9. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
    10. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
    11. Boston Scientific Completes Acquisition of Sadra Medical
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... July 1, 2015 Radiant Insights ... Stationary Oxygen Concentrators Market Shares, Strategy, and Forecasts, ... achieve continuing growth as the aging population worldwide needs ... respiratory conditions where oxygen is able to improve the ... devices have become affordable and support a mobile lifestyle ...
    (Date:7/1/2015)... July 1, 2015 New exchange plan enrollees ... 2015 compared to the same time a year ago, ... (NASDAQ: ESRX ) Exchange Pulse™ report, released today. ... 2014, the number of new exchange plan enrollees who ... in the first quarter of 2015. However, when evaluating ...
    (Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
    Breaking Medicine Technology:Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
    ... , , LARGO, Fla., Dec. 22 ... UVI) today announced that the shareholders of Unilens Vision Inc. ... of its shares at the extraordinary general meeting of its ... be voted, 1,154,767 common shares (or 48.9%) were voted at ...
    ... KONG, Dec. 22 /PRNewswire-Asia/ -- A young Olympic champion,volunteered to ... On Dec. 20, 2009, Xiong Ni became the first health ... an honor,to have him promote the application of endoscopic diagnostic ... "Endoscopic medicine is closely related to sports. More ...
    Cached Medicine Technology:Unilens Announces Extraordinary Meeting Results 2Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World 2Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World 3
    (Date:7/1/2015)... ... 2015 , ... As if mood swings, cramps and child labor weren’t enough ... leg pain. Northeast Houston Vein Center is offering tips on the treatment options for ... is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, restless legs, cramps ...
    (Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying the High-Cost ... was published July 1st and is available at: http://www.hcttf.org/resouces-tools . , The ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Boar’s ... helping families get ready for Independence Day celebrations with new takes on classic ... versatile options are perfect for any summertime get together. , “Celebrating with family, ...
    (Date:7/1/2015)... ... , ... Author Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But ... support of the practice; a terrible car accident years ago left her injured and in ... Need It ? (And What if I Do?): Answers to All Your Questions about Plastic ...
    (Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Who doesn’t ... and purpose in life with a healthy balance between work and life, and positive ... in her new book, Positive Health: Flourishing Lives, Wellbeing in Doctors. , With a ...
    Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2
    ... GenVec, Inc. (Nasdaq: GNVC ) announced that it will ... on Thursday, August 6, 2009 after market close. GenVec will hold ... 2009 to discuss the company,s second quarter results. , ... ) , , To listen to the live ...
    ... ATLANTA, July 30 CryoLife, Inc. (NYSE: ... cardiovascular tissue processing company, announced today that revenues for the ... record of $28.2 million compared to $27.2 million for the ... of $44,000 and $297,000 for the second quarters of 2009 ...
    ... , NEW YORK, July 30 The growth ... target treatments to patients through the use of information about an ... is expected to increase the number of alliances between diagnostic and ... LLP (PwC) report entitled Diagnostics 2009: Moving towards personalized ...
    ... , , , ... a leading provider of comprehensive home health services, today reported the following 2009 ... Net revenues of $298.1 million for the quarter ended June 28, ... its CareCentrix business unit, for the quarter ended June 29, 2008. Excluding prior ...
    ... , , ... Board: NWCI) a cardiac diagnostic and services company, today announced ... suite, NewCardio,s first commercial product, as the technology that will ... (TQT) studies. , , The pharmaceutical ...
    ... , , ... leading provider of information and business intelligence for students, professionals ... pharmaceutical industry, today launched an enhanced version of AdisOnline ( ... providing a host of user-customizable features and purchasing options that ...
    Cached Medicine News:Health News:GenVec Announces Second Quarter 2009 Results Conference Call 2Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 2Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 3Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 4Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 5Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 6Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 7Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 8Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 9Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 10Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 11Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 12Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 13Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 14Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 15Health News:Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers 2Health News:Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers 3Health News:Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers 4Health News:Gentiva Reports Second Quarter 2009 Results 2Health News:Gentiva Reports Second Quarter 2009 Results 3Health News:Gentiva Reports Second Quarter 2009 Results 4Health News:Gentiva Reports Second Quarter 2009 Results 5Health News:Gentiva Reports Second Quarter 2009 Results 6Health News:Gentiva Reports Second Quarter 2009 Results 7Health News:Gentiva Reports Second Quarter 2009 Results 8Health News:Gentiva Reports Second Quarter 2009 Results 9Health News:Gentiva Reports Second Quarter 2009 Results 10Health News:Gentiva Reports Second Quarter 2009 Results 11Health News:Gentiva Reports Second Quarter 2009 Results 12Health News:Gentiva Reports Second Quarter 2009 Results 13Health News:Gentiva Reports Second Quarter 2009 Results 14Health News:Gentiva Reports Second Quarter 2009 Results 15Health News:Gentiva Reports Second Quarter 2009 Results 16Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 2Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 3
    ... laboratory information system (LIS) with the ... deliver - high ROI, a secure ... LabWeb features advanced functionality like rules-based ... in-depth analysis, and quality assurance and ...
    ... II is the industrys most powerful ... Offering an impressive range of features ... complex network LIS packages, Beethoven II ... laboratory operations. The system has been ...
    Velocity works cooperatively with LabSofts LabNet LIS, allowing the convenience of 24-hour access to information from satellite lab locations, hospitals, physician offices and even homes....
    ... IntelliLab is a full-featured laboratory ... processing requirements,of clinical laboratories in ... IntelliLab provides order,management, barcode label ... and reporting tools to,ensure that ...
    Medicine Products: